Am J Transplant, Volume 20, Suppl 3 Archives - Page 68 of 223 - ATC Abstracts

2020 American Transplant Congress
Incidence, Risk Factors, and Kidney Transplant Outcomes Associated with Post-Transplant Diabetes Mellitus
R. F. Malik¹, Y. Jia¹, S. G. Mansour², I. E. Hall², M. D. Doshi², P. P. Reese², P. Singh², M. N. Harhay², F. L. Weng², H. Thiessen Philbrook¹, B. Schröppel², T. Muthukumar², J. S. Bromberg², E. Akalin², S. Mohan², C. R. Parikh¹
¹Johns Hopkins University, Baltimore, MD, ²DDS Consortium, Baltimore, MD
*Purpose: Post-Transplant Diabetes Mellitus (PTDM) is a common complication after kidney transplant (KT). Most prior studies are single-center with short follow-up and inconsistent outcome ascertainment.…
2020 American Transplant Congress
Third and Fourth Kidney Re-Transplants: A 20-Year Single Centre Experience
O. O. Okidi¹, A. Hassan¹, S. Bhutani¹, A. Summers¹, K. Poulton², C. Fullwood¹, D. VanDellen¹, J. Worthington², T. Augustine¹
¹Transplant and Endocrine Surgery, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, United Kingdom, ²Transplantation Laboratory, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, United Kingdom
*Purpose: Re-transplantation may be associated with management dilemmas including repeat allocation of limited kidney allografts to same individuals in the face of an increasing waiting…
2020 American Transplant Congress
Technology Access, Use, and Intent among Kidney Transplant Candidates Vulnerable to Health Disparities
S. Smith¹, M. Keller², R. Seibert³, L. Kayler¹
¹Transplant, Transplant and Kidney Care Regional Center of Excellence, Erie County Medical Center, Buffalo, NY, ²Transplant, University at Buffalo, State University of New York, Department of Community Health and Health Behavior, Buffalo, NY, ³Transplant, University at Buffalo, State University of New York, Department of Epidemiology and Environmental Health, Buffalo, NY
*Purpose: Advances in eHealth have created opportunities to reach vulnerable populations, however, eHealth strategies could paradoxically increase health disparities if vulnerable individuals lack technology access…
2020 American Transplant Congress
Successful Transplantation of the Kidney Graft with 5 Arteries and Intimal Dissection Injury – 9 Year Follow Up
P. J. Bachul¹, A. Perez-Gutierrez¹, R. Saoud¹, B. Juengel¹, D. J. Grybowski¹, P. Borek¹, R. Anteby², A. Lucander¹, M. Dimitrov¹, J. Fung¹, P. Witkowski¹
¹Surgery, University of Chicago, Chicago, IL, ²Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
*Purpose: Utilization of the Carrel patch allows easier implantation of the kidney graft with multiple small renal arteries. If it is not feasible, side-to-side renal…
2020 American Transplant Congress
Outcomes of Post-Transplant Desensitization in High Immunological Risk Deceased Donor Kidney Transplant Recipients
D. Kumar, C. Song, L. Kamal, I. Moinuddin, M. Levy, C. Bhati, A. King, P. Kimball, G. Gupta
Virginia Commonwealth University, Richmond, VA
*Purpose: The kidney allocation system (KAS) was changed in 2015 to increase access to transplants for highly sensitized patients. However, recent data suggests that even…
2020 American Transplant Congress
A Single-Center Experience in Transfusion-Free Liver Transplantation: Referrals and Outcomes from 2005 to 2019
B. H. Horwich¹, A. Mulgaonkar¹, B. Kim², N. Kaur¹, J. Kahn², Y. Genyk³, A. Ahearn³, H. Han²
¹Internal Medicine, University of Southern California, Los Angeles, CA, ²GI & Liver Diseases, University of Southern California, Los Angeles, CA, ³Surgery, University of Southern California, Los Angeles, CA
*Purpose: The Jehovah’s Witnesses is a religious group known to the medical community for its non-acceptance of blood products. This poses a significant challenge in…
2020 American Transplant Congress
Predicting the Safe Use of Deceased after Circulatory Death Liver Allografts in Primary Sclerosing Cholangitis
V. Fleetwood, A. Gracon, D. Aufhauser, C. Papageorge, K. Janek, G. Leverson, D. Foley, J. Mezrich, A. D'Alessandro, L. Fernandez, D. Al-Adra
Department of Transplantation, University of Wisconsin, Madison, WI
*Purpose: The use of deceased after circulatory donation (DCD) liver allografts in patients with primary sclerosing cholangitis (PSC) is controversial given the already-increased risk of…
2020 American Transplant Congress
A Population-Based Analysis of Hepatocellular Carcinoma in Children: Identifying Optimal Surgical Treatment
I. A. Ziogas¹, L. K. Matsuoka¹, M. I. Montenovo¹, M. Izzy¹, D. J. Benedetti¹, H. N. Lovvorn III², L. A. Gillis¹, S. P. Alexopoulos¹
¹Vanderbilt University Medical Center, Nashville, TN, ²Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN
*Purpose: Hepatocellular carcinoma (HCC) constitutes 0.5% of childhood malignancies and exhibits poor prognosis. Complete tumor extirpation either by partial liver resection (LR) or liver transplantation…
2020 American Transplant Congress
Epidemiology Cytomegalovirus Infection/Disease in Kidney Transplant Recipients: A Systematic Review of Observational Studies
A. Raval¹, K. Kistler², Y. Tang¹, Y. Murata¹, D. R. Snydman³
¹Merck & Co., Inc., Kenilworth, NJ, ²Evidera, Inc., Waltham, MA, ³Tufts Medical Center, Boston, MA
*Purpose: Efficacy of several CMV anti-viral strategies has been shown in controlled trials for CMV infection/disease in kidney transplant recipients (KTRs). However, a comprehensive analysis…
2020 American Transplant Congress
Experience with a BKV-Specific, Neutralizing Monoclonal Antibody (MAU868) for Treatment of Severe BK Virus Nephropathy (BKVN) after Kidney Transplant (FDA EIND #139112)
S. C. Jordan¹, S. J. Kovacs², J. R. Abend³, N. Ammerman¹, M. Toyoda¹, C. C. Nast¹, E. Huang¹, R. Najjar¹, S. Sethi¹, A. Peng¹, K. Lim¹, M. R. Hodges⁴, A. Vo¹
¹Cedars Sinai Medical Ctr, Los Angeles, CA, ²Novartis Institutes for BioMedical Research, East Hanover, NJ, ³Novartis Institutes for BioMedical Research, Emeryville, CA, ⁴Amplyx Pharmaceuticals, San Diego, CA
*Purpose: BK viral reactivation leading to nephropathy and allograft loss in kidney transplant recipients remains a significant challenge. No effective BKV-therapies are currently available. Management…